Turkish Abstract Abstract Article PDF Similar Articles Mail to Author

Ankara University Faculty of Medicine, Department of Ophthalmology, Ankara/TURKEY Proliferative diabetic retinopathy (PDR) is an important cause of visual loss in diabetes. The standart therapy is panretinal laser photocoagulation. Because of the complications of PRP, alternative and adjunctive therapeutic strategies have been explored. Anti-VEGF agents which have been used successfully in diabetic macular edema (DME), has emerged as a promising treatment in PDR. This review summarizes the results of anti-VEGF therapy for vitreous hemorrhage, neovascularizations unresponsive to PRP and before PPV for tractional retinal detachments. Keywords : Proliferative diabetic retinopathy, neovascularization, vitreous hemorrhage, pegaptanib, ranibizumab, bevacizumab